Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study
{{output}}
Objective: This study evaluated the efficacy and hepatic safety of first-line chemoimmunotherapy in lung cancer patients according to baseline hepatitis B surface antigen (HBsAg) status, and explored whether baseline anti-HBs lev... ...
